Title : COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models.

Pub. Date : 2014 Jun 25

PMID : 24964992






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We identified prostaglandin E2 (PGE2) as a soluble tumor-derived angiogenic factor associated with VEGF-independent angiogenesis. Dinoprostone vascular endothelial growth factor A Homo sapiens
2 We identified prostaglandin E2 (PGE2) as a soluble tumor-derived angiogenic factor associated with VEGF-independent angiogenesis. Dinoprostone vascular endothelial growth factor A Homo sapiens
3 PGE2 production in preclinical breast and colon cancer models was tightly controlled by cyclooxygenase-2 (COX-2) expression, and COX-2 inhibition augmented VEGF pathway blockade to suppress angiogenesis and tumor growth, prevent metastasis, and increase overall survival. Dinoprostone vascular endothelial growth factor A Homo sapiens
4 These results demonstrate the importance of the COX-2/PGE2 pathway in mediating resistance to VEGF pathway blockade and could aid in the rapid development of more efficacious anticancer therapies. Dinoprostone vascular endothelial growth factor A Homo sapiens